Mega Cap Healthcare
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Eli Lilly
LLY
$1.26T
| $1.26T | $1,417.54 | 3.19% |
|
2
Johnson & Johnson
JNJ
$658B
| $658B | $273.20 | 0.73% |
|
3
AbbVie
ABBV
$521B
| $521B | $294.89 | 1.41% |
|
4
Merck
MRK
$369B
| $369B | $149.52 | 2.18% |
|
5
UnitedHealth
UNH
$365B
| $365B | $406.97 | 0.96% |
|
6
Novartis
NVS
$304B
| $304B | $160.79 | 0.19% |
|
7
AstraZeneca
AZN
$289B
| $289B | $186.65 | 7.02% |
|
8
Thermo Fisher Scientific
TMO
$258B
| $258B | $697 | 1.72% |
|
9
Amgen
AMGN
$252B
| $252B | $466.01 | 1.15% |
|
10
Gilead Sciences
GILD
$212B
| $212B | $170.68 | 3.06% |
|
Mega Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 10 mega cap Healthcare stocks — companies in the Healthcare sector with a market cap over $200B — worth a combined $4.49T.
The largest by market cap are Eli Lilly (LLY) at $1.26T, Johnson & Johnson (JNJ) at $658B and AbbVie (ABBV) at $521B.
Among institutional investors, UnitedHealth (UNH) drew the most net new fund positions in Q2 2026: 531 funds opened new positions, taking total fund holders up 348 (11%) quarter-over-quarter.
- Combined market cap: $4.49T across 10 stocks.
- Mega Cap: market cap over $200B.
- Largest constituent: Eli Lilly (LLY), $1.26T market cap.
- Most net new fund positions in Q2 2026: UnitedHealth (UNH), +348 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.